Optimized for musculoskeletal assessment, needle guidance and vascular access, the PocketPro H2 wireless ultrasound unit reportedly provides 90 minutes of high-quality continuous scanning for point-of-care applications.
Combining ease of use features, strong compatibility with existing systems and robust image quality, Konica Minolta has launched the handheld, wireless ultrasound device PocketPro H2.
The ultrasound device reportedly facilitates rapid soft tissue assessment of ligaments, muscles, cartilage, inflammation, and joint instability, according to Konica Minolta. The company said clinicians can also employ the PocketPro H2 ultrasound for vascular access and needle guidance applications.
In addition to color and pulsed-wave Doppler capabilities and M-Mode functions, the PocketPro H2 offers an ergonomic design and customized imaging presets that promote ease of use.
The company noted a downloadable app allows wireless connection of the PocketPro H2 to the majority of iOS and Android smart devices and viewing of images at the point of care. Fully DICOM-compatible, the PocketPro H2 can also be linked to any PACS platform, according to Konica Minolta.
“Ultrasound has been called the new stethoscope of the 21st century and this advanced, wireless handheld unit helps clinicians do more with ultrasound at the point of care,” noted Joan Toth, a senior product marketing manager of ultrasound at Konica Minolta Healthcare.
(Editor’s note: For related content, see “Philips Set to Showcase Ultrasound Compact 5500CV at ASE Conference” and “New System Combines Diagnostic Ultrasound and Transient Elastography.”)
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.